Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

188 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation.
Berardesca E, Cameli N, Cavallotti C, Levy JL, Piérard GE, de Paoli Ambrosi G. Berardesca E, et al. J Cosmet Dermatol. 2008 Mar;7(1):8-14. doi: 10.1111/j.1473-2165.2008.00355.x. J Cosmet Dermatol. 2008. PMID: 18254805 Clinical Trial.
In vivo tretinoin-induced changes in skin mechanical properties.
Berardesca E, Gabba P, Farinelli N, Borroni G, Rabbiosi G. Berardesca E, et al. Br J Dermatol. 1990 Apr;122(4):525-9. doi: 10.1111/j.1365-2133.1990.tb14729.x. Br J Dermatol. 1990. PMID: 2337520 Clinical Trial.
Instrumental evaluation of cutaneous hydration.
Berardesca E, Borroni G. Berardesca E, et al. Clin Dermatol. 1995 Jul-Aug;13(4):323-7. doi: 10.1016/0738-081x(95)00072-n. Clin Dermatol. 1995. PMID: 8665440 Review. No abstract available.
Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study.
Berardesca E, Barbareschi M, Veraldi S, Pimpinelli N. Berardesca E, et al. Contact Dermatitis. 2001 Nov;45(5):280-5. doi: 10.1034/j.1600-0536.2001.450505.x. Contact Dermatitis. 2001. PMID: 11722487 Clinical Trial.
Disturbances of skin barrier function occur in several skin diseases, e.g., atopic dermatitis (AD), irritant/allergic contact dermatitis (ICD, ACD). ...
Disturbances of skin barrier function occur in several skin diseases, e.g., atopic dermatitis (AD), irritant/allergic contact dermati …
Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types.
Fluhr JW, Kuss O, Diepgen T, Lazzerini S, Pelosi A, Gloor M, Berardesca E. Fluhr JW, et al. Among authors: berardesca e. Br J Dermatol. 2001 Nov;145(5):696-703. doi: 10.1046/j.1365-2133.2001.04431.x. Br J Dermatol. 2001. PMID: 11736891
Impact of anatomical location on barrier recovery, surface pH and stratum corneum hydration after acute barrier disruption.
Fluhr JW, Dickel H, Kuss O, Weyher I, Diepgen TL, Berardesca E. Fluhr JW, et al. Among authors: berardesca e. Br J Dermatol. 2002 May;146(5):770-6. doi: 10.1046/j.1365-2133.2002.04695.x. Br J Dermatol. 2002. PMID: 12000372
RESULTS: Lipid-rich skin areas (e.g. the forehead) were the most vulnerable to barrier disruption by either method. While acetone treatment affected barrier function and decreased stratum corneum hydration, tape stripping similarly altered barrier function but increased ca …
RESULTS: Lipid-rich skin areas (e.g. the forehead) were the most vulnerable to barrier disruption by either method. While acetone tre …
Cytokine profiles during infliximab monotherapy in psoriatic arthritis.
Mastroianni A, Minutilli E, Mussi A, Bordignon V, Trento E, D'Agosto G, Cordiali-Fei P, Berardesca E. Mastroianni A, et al. Among authors: berardesca e. Br J Dermatol. 2005 Sep;153(3):531-6. doi: 10.1111/j.1365-2133.2005.06648.x. Br J Dermatol. 2005. PMID: 16120138 Clinical Trial.
At baseline and before every infusion blood samples were taken to assess serum cytokine levels [TNF-alpha, interleukin (IL-6), E-selectin, vascular endothelial cell growth factor (VEGF), fibroblast growth factor (FGF), matrix metalloproteinase (MMP-2)]. ...In contrast, IL- …
At baseline and before every infusion blood samples were taken to assess serum cytokine levels [TNF-alpha, interleukin (IL-6), E-sele …
Erosive pustular dermatosis of the scalp: a case report and review of the literature.
Mastroianni A, Cota C, Ardigò M, Minutilli E, Berardesca E. Mastroianni A, et al. Among authors: berardesca e. Dermatology. 2005;211(3):273-6. doi: 10.1159/000087023. Dermatology. 2005. PMID: 16205074 Review.
Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel.
Berardesca E, Cameli N, Primavera G, Carrera M. Berardesca E, et al. Dermatol Surg. 2006 Apr;32(4):526-31. doi: 10.1111/j.1524-4725.2006.32106.x. Dermatol Surg. 2006. PMID: 16681660
A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis.
Primavera G, Carrera M, Berardesca E, Pinnaró P, Messina M, Arcangeli G. Primavera G, et al. Among authors: berardesca e. Cutan Ocul Toxicol. 2006;25(3):165-71. doi: 10.1080/15569520600860009. Cutan Ocul Toxicol. 2006. PMID: 16980242 Clinical Trial.
188 results
Jump to page
Feedback